Other posts
Even after the project is complete, we remain by your side, providing ongoing support and adjustments as needed.
Southeast Asia Medical Device Registration for Six Markets
Most teams treat Southeast Asia medical device registration as separate documents or dossiers for each country. For example, there are six different dossiers. But in reality, the paperwork is repetitive. And there are decision points regarding classification of devices and who is the local holder or distributor, local holder of a license, and preparing the CSDT, how deep it should prepare, and what will be the reliable route, and what level languages should be maintained across, and exact timelines. These are still unknown to many people, even many RA persons. Because the paperwork, for some it might seem similar, but there are many intricate differences. For some, the paperwork is the same, but still there are many differences though it is not the same. The main challenge is we need to sequence the same product, which is a core of the product, across the brands in the market. And it is not just memorizing these rule books and making them. It is understanding the concept and how to make it. This blog covers Malaysia, Indonesia, Thailand, Singapore, Vietnam, and Philippines as a one whole overview, which you can reuse and use as a guide for each market, planning for a market.
All six markets come under Southeast Asia, which we already are aware of. And it comes under a body called ASEAN Medical Device Directive Risk Logic. It classifies devices from class A to class D. And with the higher the class, the more the content on filing CSDT is applied and more detail, more testing should be done on clinical level and performance level, and more evidence needs to be attached, more literatures needs to be submitted, more review needs to be done with a very stringent manner unlike the lower classes. Foreign manufacturers cannot file alone. Sometimes they also require an authorized representative or some authorized agent or a registrant of the market to file, and they have to act as a legal holder to file and register the product in the particular market. This comes under ISO 13485. And they also need free sale or country of origin proof in most of these markets to sell. Also, clear IFU which matches with all the documents and labels and clear intended use should be there, which is expected by the respective regulatory bodies.
Do not assume that only Southeast Asia approval opens to the next market. Reliance in such markets shall help in such cases such as Singapore to Malaysia or in the Philippines using an abridged route. But it can't be helped everywhere. And also, even in these cases, authority might still have issues with the authorizations and can still check the identity of claims, labels, holder details, and request some other documents if they wanted.
Malaysia Medical Device Registration
For Malaysia medical device registration, Malaysia has MDA or MeDC@ST. A local authorized representative is required, where the output which we get is a certificate of approval to market there. And the certificate is valid for five years with the practical balance of CAB and conformity assessment before MDA.
Indonesia Medical Device Registration
For Indonesia medical device registration, the competent authority is MOH RI, and there is a need for an IPAK-licensed agent for the local pathway. Approval output is marketing authorization that is valid from two to five years, and in practice, only one legal importer is needed. Moreover, bilingual labels (in Indonesian and English) are required for all medical devices.
Thailand Medical Device Registration
For Thailand medical device registration, since Thailand allows listing at the Thai FDA or separate registration, we may choose between them. However, there is a need for a local importer or a licensee who will register or notify the FDA about the medical device. The output of registration is a listing or a license that is valid for up to five years. It is possible to automatically list class 1 devices, while other classes require a separate authorization license.
Singapore Medical Device Registration
For Singapore medical device registration, Singapore, which has an HSA. Singapore, which needs Singapore registrant, and the output we will get is SMDR listing, where annual retention or filing for retention is required. This route depends on the approvals of the reference countries.
Vietnam Medical Device Registration
For Vietnam medical device registration, which has a MOH or DAV portal, where we must find a registration holder and the output we will get is a circulation number. And once the approval is done, it is indefinite. But we should make A and B declarations and C and D CSDT reviews.
Philippines Medical Device Registration
For Philippines medical device registration, which has FDA approval or CDRRHR, and also they hold the LTO license, they need an LTO license holder, which gives a certificate in the form of CMDN, which is valid for five years. And it can also have an Southeast Asia abridged route.
For Southeast Asia medical device registration, prepare a package that can be cloned and localized before moving to any portal. The IFU must clearly state the intended purpose, device use, classification, and how the product fits the AMDD rules for device classification and risk. This must then be checked against each market reading of the class.
The second thing is that a local holder with power of attorney is a must here. In some cases, you can get away with a letter of authorization for a person or at least a legalization process in which an apostille is required.
Third thing is that the ISO 13485 certificate for the manufacturing sites in the dossier should be mentioned and it should be matched with the certificate we provide. Then the CSDT ready technical file should be there. It is mandatory for the file to contain device description, essential principles, risk management, verification or validation for the device, and clinical performance summary of the device, and performance summary in general, and then the labeling in local language and EU, and then the IFUs with all the details which are for the device.
Now finally we have reference approvals. Here for reference approval, there are few cases which have an abridged route and the other route. The abridged route, you must need approval from FDA or Health Canada or PMDA or TGA or EU MDR or notified body or any Southeast Asia NRA. Or else you can use the reliance route for Singapore, Malaysia. Then finally label and IFU language planned per market. This includes refurbished or home use variants if that is the case. But mostly the labeling and IFUs deal with language and the information which should match all other documents.
First, build your dossier on the CSDT core, which is the common skeleton for all the languages. Then as a muscle which acts, which spreads across different branches using different structures, apply the muscles over the bones to build your perfect dossier. Now we will discuss it country wise.
Malaysia Medical Device Registration Branch
For Malaysia, the muscle is CAB first and then MDA. Foreign manufacturers appoint an authorized regulatory person and the authorized regulatory person builds a CSDT. Now when this file is ready, we will make a conformity assessment through the conformity assessment body. Without CAB certification, MDA will not approve. Country of origin approval is expected also with local clinical studies. Approval takes time around nine months with a five year certificate validity. And if a device is refurbished, it is a separate path altogether. It has establishment license and GRPMD practices, whether it is following that, and whether the CAB assessment has been done, and whether the labels are marked as refurbished, and a distinct catalog with a number or suffix under the rule of MDA/ZD/0026 should be there.
Indonesia Medical Device Registration Branch
Next for Indonesia, first we need an IPAK agent and a bilingual package. Then only when we have an IPAK agent who acts as a legal importer and distributor, can we expect to enter the country. The second thing is to need an embassy legalized authorization for many years under the FSC or ISO 13485 and for risk management. The next major thing is Indonesian labels must be in both languages, English and Indonesian language, and even the leaflets and IFUs should also follow the same. Here review ranks in evaluation and deficiency cycles by classes. If the evaluation does not match and has a deficiency, then there is a review. It is done according to the classes. Accessories here are usually a part of the main registration number rather than a standalone product.
Thailand Medical Device Registration Branch
Next is Thailand. Here there is a clear cut structure on how each class should have a different pathway even in advertising and labeling. Class 1 can be automatically approved for a positive list of devices which can also vary submission.
Now, for class 2 and 3, there is a notification with CSDT regarding the rules and regulations that need to be followed. It needs to comply with the rules so that it can be approved. For class 4, the licensing process should be full regarding the Thailand owned regulatory body, so that that can be approved. An abridged path is still there, but for devices with at least a year of approval from the recognized authorities, reference authorities. And also, do not stop at product approval. Public advertising needs a separate approval which is implemented from the date 28 June 2026. And the labeling notification BE 2568 applies that Thai language for home use, IFU or labels, Thai or English for professional use, e-IFU options for SaMD, and post import labeling should be completed within 180 days with all these rules and regulations we follow.
Singapore Medical Device Registration Branch
Now, let's talk about Singapore, where we can choose the evaluation route, not just the class which our devices are. In Singapore, Class A is listed generally rather than say it is a registered one to Singapore. For class B, C, and D devices, they use a route called GN15 on SHARE, which is a full, there are multiple routes, which are full abridged route, which license from the other can be included in this, expedited or immediate route, which is a fast track method. And depending on the reference history or agency, the time taken differs. The reference agencies can include USFDA, or Health Canada, or PMDA, TGA, and EU MDR, notified bodies of EU MDR. But currently, the latest update from March 2026 states that MDA, Malaysian registration, can also support this HSA abridged route, which is intended to use, but CAB assessment should be performed after this. For borderline products and devices with a registrable medical substance, only this particular route is available, not for other devices. Further are routes of immediate B or C software. For class B and C SaMD there are a number of immediate software routes, however HSA reserves the right to cancel it upon submission checks, without refunding the paid fees. Hence, it is more advisable to make the manual process and go through the two methods. As a final point, the annual retention should always be done to maintain the listing of the SMDR. We should make the annual retention so that the product doesn't expire from the notification, and that any big changes in notification or a major change should be notified to the regulatory body on the real calendar time.
Vietnam Medical Device Registration Branch
Next is Vietnam. In Vietnam, there are two rules, declaration for A and B, CSDT review for C and D. Class A and B states that you can declare all the applicable standards which they have through the portal. But for class C and D, we need a full CSDT package and MOH technical review, and once it is done, the other will be approved. Often it takes around two to three months when the file is clean to get an approval. But this depends solely on the correctness of the file. Separate import permits are generally not needed once the circulation number exists. Once you have a circulation number, then separate import permits are not needed. And the label requires Vietnamese language and circulation number, lot number, batch number, dates, warning and storage conditions. This should be a mandatory label, and it should also be in a supplementary label if the master label is in foreign languages. From 11th September 2026 as the latest update apostille posting can replace legalization for documents from Hague Convention states.
Philippines Medical Device Registration Branch
Next, we want to differentiate CMDN versus CMDR with the Southeast Asia abridged route. Class A takes CMDN, whereas class B to D takes CMDR route. CMDR route is almost comparable with CSDT content. And LTO is mandatory for local establishments to import your goods. Now, typically reviewing the review period takes around 3 to 6 months. Authorization, once review is done and we get an authorization, it can be valid for up to 5 years. Under FDA, class B to D devices already approved by another Southeast Asia NRA, notified body under AMDD CSDT can use abridged methods. That is, the already approved devices can use an abridged method. And the device and dossier match the reference.
The first bundle is identity and the holder, which contains manufacturer details, site list, and ISO 13485 compliance certificate. This can be reused across all markets, so it should be bundled. But what changes across markets is POA or LOA format for legalization, or apostille format, or AR register, or IPAK LTO details, or even class depth for CSDT technical code documents.
The device description is similar, the essential principles are similar, and the risk classification file is similar. V and V and clinical performance study of the device is similar. But the class depth, that is whether it is A or B or C or D, and the evidence, and market specific form which should be filled for these classes, is different.
For market proof, reference approvals and certificates and even declaration of conformity is similar. But CFS or safety effectiveness attestation, or CAB for Malaysia, are different.
Regarding labeling and IFU, the master English and artwork claims should be similar. But Indonesian, Thailand, and Vietnam languages have their own rules, and refurbishment home use should be labeled separately in some countries. e-IFUs were allowed in some countries. These are the differences.
In post approval, the PMS or vigilance process is similar, but the annual retention differs in Singapore, whereas adverse reactions localize across markets in Thailand, and changes in notification differ across the Southeast Asia countries.
Morula can support local holder coordination, CSDT preparation, reliance route and selections, and multi market submission across these six Southeast Asia countries.
Wrong class or wrong pathway
Most of them file them in the wrong class or choose the wrong pathway for their device. This happens because AMDD class is different from what class A or class C detailed in EU MDR or FDA. So that's where this occurs. It is even different from the Southeast Asia countries themselves. What Morula does to help is, we will remap the classification as per the classification in AMDD and verify it and pick CMDN or CMDR for declaration and registration and listing as a license. So the classification won't miss.
Holder papers were incomplete
For example, most of the people miss IPAK LTO or an authorized representative appointment or a legalized power of attorney. But what Morula does is, we issue market authorization correctly and plan apostille or legalization if required, and with the proper lead time given. So we avoid the rejection.
Reliance refused
For example, most people intend to use changes from documents and different, mostly it is different for devices, but they use the same for the whole family. And it is excluded in the product type also. But what Morula does is, keep claims identical to the reference, and then we also mention the exclusions separately. So this prevents me from getting rejected.
Here, what everyone does is, evidence summary will not be there or site certification will be outdated. But what Morula does is, we match the ISO 13485 versus scope, essential principles and performance summaries, so that before review, all will be sorted out and match the CAB and MOH and CAB review.
Label or language compliance
Most people use the English only pack where local language is even mandatory. What we will do is, we will build a separate subcategory label or even translate the main category label according to the Thailand, Indonesia, or Vietnamese language. So variance in the artwork schedule, it is different for each and according to their own style and language they use. Not just as a copy paste and translating thing.
Post approval drift
Whatever the changes they have made from the signing of approval and after getting the approval in the PSUR process, they will not notify it. So this means, RAs miss the deadline to notify, this makes an advertisement without getting certified in time. This means direct rejection. But what we do is, assign an owner for all these processes and retention fees, process like retention fees, change control and advertising license per market.
Other posts
Even after the project is complete, we remain by your side, providing ongoing support and adjustments as needed.